Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
about
Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Dexamethasone as adjuvant ther ...... due to Staphylococcus aureus.
@en
Dexamethasone as adjuvant ther ...... due to Staphylococcus aureus.
@nl
type
label
Dexamethasone as adjuvant ther ...... due to Staphylococcus aureus.
@en
Dexamethasone as adjuvant ther ...... due to Staphylococcus aureus.
@nl
prefLabel
Dexamethasone as adjuvant ther ...... due to Staphylococcus aureus.
@en
Dexamethasone as adjuvant ther ...... due to Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Dexamethasone as adjuvant ther ...... s due to Staphylococcus aureus
@en
P2093
Angelos Pefanis
Apostolos Papalois
Aspasia Kyroudi
Ioannis Skiadas
Thomas Tsaganos
P2860
P304
P356
10.1128/AAC.01376-06
P407
P577
2007-06-11T00:00:00Z